NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Company watch back to previous page show list
AstraZeneca »24/04/2007 [Company watch]
AStra Zeneca are advertising for :TRANSLATIONAL SCIENTIST for pre-clinical development in cancer research

AStra Zeneca are seeking an experienced scientist to lead pre clinical cancer trials team in the Shanghai Innovation Centre - full job advert below, to be fully operational by 2009

 

 

Take the Opportunity
Make Great things happen!

ASTRAZENECA is one of the world's leading pharmaceutical companies with R&D spend $3.4 billion for 11 R&D centers globally in 2005. Now it represents over 65,000 people worldwide in R&D, manufacturing and marketing of pharmaceuticals and healthcare services
ASTRAZENECA has invested $100 Million in establishing a state of the art drug research facility / innovation center in Shanghai, China (ICC).

ICC will concentrate on cancer research, with focus on biomarker development and translational science, and will develop scientific expertise for Chinese patients. By 2009, the fully established Innovation Centre will consist of approximately 70 top international scientists supported with cutting edge science and technology. To lead this deployment and to ensure high quality research, ASTRAZENECA is now offering a unique opportunity

The Best Translational Scientist

Reporting directly to the head of the ICC, you will set up
& lead pre-clinical development

After an initial training at ASTRAZENECA UK research center you will, together with two colleagues and the Head of ICC, constitute and train the research team that should consist of the best scientists within cancer research (Experts in FISH, ISH, IHC etc¡)

With the team established in the new facilities you will initiate and execute translational science research projects and provide scientific strategies in support of the global drug discovery and development programs.
You will lead a group of cross-functional scientists in cell biology, genetics and immunohistochemistry and deliver translational data packages to guide and support clinical development of our candidate drugs.

Furthermore you will initiate and manage external scientific interaction and collaboration with key opinion leaders in related fields.

To meet this challenge you are MD or PhD in Biological or Medical Sciences with +5 years research experience in one of the following biological effect areas: growth factor/survival, angiogenesis, and cell cycle control.
You have demonstrated excellent leadership and cross functional communication ability

You are committed to team leading with a high level of professionalism, personal ethics and a can-do attitude. You are motivated by challenges and you have a profound passion for science and research

A competitive career development path and competitive packages are offered

For more information about this position or to apply directly, please send your contact information and / or CV to career.cn@mercuriurval.com


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.